FoRx Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeFoRx Therapeutics
FoRx Therapeutics logo

FoRx Therapeutics

0 followers

About FoRx Therapeutics

FoRx Therapeutics is a privately-held biotechnology company focused on developing first-in-class cancer therapeutics by targeting DNA replication stress and DNA damage response pathways. Based in Basel, Switzerland, the team combines expertise in cancer biology, genomics, biochemistry, medicinal chemistry, and small molecule drug discovery to identify molecular targets involved in replication fork repair for targeted anticancer drugs.

Recent News

Recent Deals

Key Team Members

Tarig Bashir

CEO

Ulrich Lücking

Head of Chemistry

Jens Würthner

Chief Medical Officer

Frank Zenke

CSO

Key Facts

HQ Location

Basel, Switzerland

Founded

2019

Employees

11 - 50

Status

Private

Website

https://forxtherapeutics.com